Free Trial

Avanos Medical (AVNS) Competitors

Avanos Medical logo
$10.86 +0.16 (+1.50%)
Closing price 03:59 PM Eastern
Extended Trading
$10.84 -0.02 (-0.18%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVNS vs. PRCT, LMAT, AORT, LQDA, ENOV, NVCR, CDRE, CNMD, SSII, and PLSE

Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), Liquidia Technologies (LQDA), Enovis (ENOV), NovoCure (NVCR), Cadre (CDRE), CONMED (CNMD), SS Innovations International (SSII), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry.

Avanos Medical vs. Its Competitors

PROCEPT BioRobotics (NASDAQ:PRCT) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

PROCEPT BioRobotics has higher earnings, but lower revenue than Avanos Medical. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PROCEPT BioRobotics$224.50M8.18-$91.41M-$1.55-21.29
Avanos Medical$692.50M0.73-$392.10M-$10.07-1.08

PROCEPT BioRobotics has a net margin of -30.60% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat PROCEPT BioRobotics' return on equity.

Company Net Margins Return on Equity Return on Assets
PROCEPT BioRobotics-30.60% -23.73% -17.34%
Avanos Medical -66.89%6.16%4.57%

PROCEPT BioRobotics has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500.

In the previous week, PROCEPT BioRobotics had 6 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for PROCEPT BioRobotics and 0 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.87 beat PROCEPT BioRobotics' score of 0.85 indicating that Avanos Medical is being referred to more favorably in the news media.

Company Overall Sentiment
PROCEPT BioRobotics Positive
Avanos Medical Very Positive

PROCEPT BioRobotics presently has a consensus target price of $70.00, suggesting a potential upside of 112.12%. Given PROCEPT BioRobotics' stronger consensus rating and higher possible upside, equities analysts clearly believe PROCEPT BioRobotics is more favorable than Avanos Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PROCEPT BioRobotics
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.60
Avanos Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

89.5% of PROCEPT BioRobotics shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 17.4% of PROCEPT BioRobotics shares are held by company insiders. Comparatively, 2.6% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

PROCEPT BioRobotics beats Avanos Medical on 9 of the 16 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVNS vs. The Competition

MetricAvanos MedicalMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$503.93M$6.89B$6.04B$21.68B
Dividend YieldN/A1.17%5.73%3.64%
P/E Ratio-1.0826.2185.3129.62
Price / Sales0.73191.04589.4495.25
Price / Cash0.9021.8525.7317.79
Price / Book0.605.1712.664.63
Net Income-$392.10M$176.38M$3.31B$1.01B
7 Day Performance-6.14%-1.46%-0.44%-1.84%
1 Month Performance-11.20%6.91%8.70%0.55%
1 Year Performance-51.88%24.74%76.70%13.43%

Avanos Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVNS
Avanos Medical
1.9913 of 5 stars
$10.86
+1.5%
N/A-52.5%$503.93M$692.50M-1.082,227Positive News
PRCT
PROCEPT BioRobotics
2.9768 of 5 stars
$35.24
-2.0%
$70.00
+98.6%
-54.1%$2.00B$224.50M-22.74430
LMAT
LeMaitre Vascular
3.9138 of 5 stars
$87.49
-0.4%
$97.60
+11.6%
-5.0%$1.99B$219.86M42.47490
AORT
Artivion
3.2425 of 5 stars
$40.79
-0.6%
$43.13
+5.7%
+55.1%$1.94B$388.54M-97.121,600Analyst Forecast
LQDA
Liquidia Technologies
3.3573 of 5 stars
$22.86
+1.9%
$32.38
+41.6%
+109.5%$1.93B$14M-13.4550
ENOV
Enovis
3.6414 of 5 stars
$31.30
-2.2%
$51.00
+62.9%
-26.2%$1.83B$2.11B-2.207,367News Coverage
Positive News
NVCR
NovoCure
4.1761 of 5 stars
$14.50
-1.1%
$27.50
+89.7%
-14.3%$1.64B$605.22M-9.291,488
CDRE
Cadre
2.5022 of 5 stars
$37.54
+2.4%
$31.50
-16.1%
-4.6%$1.49B$567.56M39.932,284Analyst Forecast
Analyst Revision
CNMD
CONMED
4.5452 of 5 stars
$46.42
-3.6%
$59.80
+28.8%
-33.5%$1.49B$1.31B13.153,900
SSII
SS Innovations International
N/A$6.80
-5.4%
N/AN/A$1.39B$20.65M0.004
PLSE
Pulse Biosciences
3.7466 of 5 stars
$19.45
+0.8%
$22.00
+13.1%
+3.0%$1.30B$700K-18.52140

Related Companies and Tools


This page (NYSE:AVNS) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners